Life sciences news
-
VUB scientist Mathieu Vinken coordinates prestigious European research into animal-free methods for testing chemical substances
Wednesday February 3rd 2021
Read more
-
argenx announces “GO” Decision in ADHERE trial of Efgartigimod in Chronic Inflammatory Demyelinating Polyneuropathy following interim analysis
Tuesday February 2nd 2021
Read more
-
Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study
Tuesday January 12th 2021
Read more
-
Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study
Tuesday December 22nd 2020
Read more
-
Mithra announces positive DSMB safety review and continuation of its Phase III Clinical Program Donesta® in menopause
Wednesday December 16th 2020
Read more
-
Galapagos announces first dosing in MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
Thursday December 3rd 2020
Read more
-
reMYND commences first-in-human trial of ReS19-T Alzheimer’s program
Thursday December 3rd 2020
Read more
-
Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial
Tuesday December 1st 2020
Read more
-
Your news here?
-
Biocartis announces publication of large multi-center comparison study with Idylla™ MSI Assay showing very low failure rates and excellent concordance with reference methods
Tuesday November 17th 2020
Read more
-
First patient dosed with GLPG3667 in psoriasis patient Phase 1b trial
Tuesday November 10th 2020
Read more
-
Bone Therapeutics reaches 50% treated patients in ongoing JTA-004 Phase III pivotal knee osteoarthritis study
Tuesday October 20th 2020
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator